CheckMan Stock Market Overview

SAN FRANCISCO, Oct. 1, 2026 /PRNewswire/ -- On September 8, 2026, investors in Stryker Corporation (NYSE: SYK) saw the price of their shares fall $26.70 (-8.8%) after the company's CFO revealed that a previously-thought resolved manufacturing issue persists. The move lower wiped out over $10 billion of Stryker's market capitalization.

NFG's $2.62 billion Ohio gas utility acquisition adds 335,000 customers, doubles its rate base and boosts regulated cash flow and investment potential.

Will invest to build championship-calibre teams Will invest to deliver world-class experiences to fans and customers Becomes global communications, sports and entertainment leader

CNBC's MacKenzie Sigalos joins 'The Exchange' to discuss Google unveiling Gemini 4 Argon. Argon is Alphabet's most advanced artificial intelligence model yet, offering major improvements in coding, cybersecurity, and complex professional work.

Gold prices have managed to hold their ground in the face of surging bond yields and rising interest rate expectations, but one bank expects the current headwinds will eventually prove to be too much for the precious metal.

Shares in the toy maker dropped 4% Wednesday after it named a new CEO.

Micron just delivered a record-shattering quarter highlighted by explosive earnings growth, unmatched revenue visibility, and a compelling valuation.

Lamb Weston Holdings, Inc. trades at depressed valuation multiples, reflecting skepticism about its cyclical earnings power and recent operational missteps. Current 8.3x EV/EBITDA and 13.5x normalized FCF multiples imply little growth, despite the potential for margin recovery and double-digit returns if execution improves. Restoring investor confidence hinges on management's ability to stabilize margins, avoid further self-inflicted errors, and demonstrate credible execution amid external headwinds.

CLX's innovation, GOJO acquisition and digital transformation are strengthening its health and hygiene portfolio while supporting long-term growth.

Constellium remains a Strong Buy as structural margin improvements and robust segment performance drive raised guidance and early achievement of 2028 targets. CSTM's pass-through model and strong operating leverage enable high incremental margins, with adjusted EBITDA now guided to $980M–$1.02B for 2026 and FCF over $300M. Risks from potential tariff reductions and Midwestern Premium normalization are mitigated by resilient historical EBITDA and ongoing capacity expansion.